These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 30801340
1. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Am J Dermatopathol; 2019 Mar; 41(3):167-179. PubMed ID: 30801340 [Abstract] [Full Text] [Related]
2. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z, Buljan M, Busam KJ. J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [Abstract] [Full Text] [Related]
3. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp. Costa S, Byrne M, Pissaloux D, Haddad V, Paindavoine S, Thomas L, Aubin F, Lesimple T, Grange F, Bonniaud B, Mortier L, Mateus C, Dreno B, Balme B, Vergier B, de la Fouchardiere A. Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730 [Abstract] [Full Text] [Related]
4. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors. Garfield EM, Walton KE, Quan VL, VandenBoom T, Zhang B, Kong BY, Isales MC, Panah E, Kim G, Gerami P. J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057 [Abstract] [Full Text] [Related]
5. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations. Piris A, Mihm MC, Hoang MP. Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927 [Abstract] [Full Text] [Related]
6. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations. Mochel MC, Piris A, Nose V, Hoang MP. Am J Clin Pathol; 2015 Jun; 143(6):901-4. PubMed ID: 25972334 [Abstract] [Full Text] [Related]
7. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes. Busam KJ, Sung J, Wiesner T, von Deimling A, Jungbluth A. Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932 [Abstract] [Full Text] [Related]
8. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. Gerami P, Yélamos O, Lee CY, Obregon R, Yazdan P, Sholl LM, Guitart GE, Njauw CN, Tsao H. JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183 [Abstract] [Full Text] [Related]
9. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. Busam KJ, Wanna M, Wiesner T. JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620 [Abstract] [Full Text] [Related]
10. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297 [Abstract] [Full Text] [Related]
11. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study. Cabaret O, Perron E, Bressac-de Paillerets B, Soufir N, de la Fouchardière A. Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743 [Abstract] [Full Text] [Related]
12. Novel insights into the BAP1-inactivated melanocytic tumor. Donati M, Martinek P, Steiner P, Grossmann P, Vanecek T, Kastnerova L, Kolm I, Baneckova M, Donati P, Kletskaya I, Kalmykova A, Feit J, Blasch P, Szilagyi D, Baldi A, Persichetti P, Crescenzi A, Michal M, Kazakov DV. Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909 [Abstract] [Full Text] [Related]
13. Immunoexpression of BAP1, ROS1, and ALK in Spitzoid Melanocytic Tumors. Cardili L, Viana CR, Germano A, Fernandes M, Barcellos D, Landman G. Int J Surg Pathol; 2018 Sep; 26(6):514-520. PubMed ID: 29623743 [Abstract] [Full Text] [Related]
14. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Betti M, Aspesi A, Biasi A, Casalone E, Ferrante D, Ogliara P, Gironi LC, Giorgione R, Farinelli P, Grosso F, Libener R, Rosato S, Turchetti D, Maffè A, Casadio C, Ascoli V, Dianzani C, Colombo E, Piccolini E, Pavesi M, Miccoli S, Mirabelli D, Bracco C, Righi L, Boldorini R, Papotti M, Matullo G, Magnani C, Pasini B, Dianzani I. Cancer Lett; 2016 Aug 10; 378(2):120-30. PubMed ID: 27181379 [Abstract] [Full Text] [Related]
16. BAP1-deficient and VE1-negative atypical Spitz tumor. Requena C, Sanz V, Nagore E, García-Casado Z, Rubio L, Guillén C, Kutzner H. J Cutan Pathol; 2015 Aug 10; 42(8):564-7. PubMed ID: 25953246 [Abstract] [Full Text] [Related]
17. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome. Louw A, Creaney J, Thomas A, Van Vliet C, Harvey NT, Wood BA, Mesbah Ardakani N. Am J Dermatopathol; 2020 Nov 10; 42(11):872-875. PubMed ID: 32649346 [Abstract] [Full Text] [Related]
19. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature. Wysozan TR, Khelifa S, Turchan K, Alomari AK. J Cutan Pathol; 2019 Nov 10; 46(11):852-857. PubMed ID: 31206729 [Abstract] [Full Text] [Related]
20. BAP1-Inactivated Melanoma Arising From BAP1-Inactivated Melanocytic Tumor in a Patient With BAP1 Germline Mutation: A Case Report and Review of the Literature. Donati M, Šteiner P, Kazakov DV. Am J Dermatopathol; 2023 Feb 01; 45(2):117-122. PubMed ID: 36669076 [Abstract] [Full Text] [Related] Page: [Next] [New Search]